Free Trial

MorphoSys (MOR) SEC Filings & 10K Form

$18.55
+0.01 (+0.05%)
(As of 05/28/2024 ET)

Recent MorphoSys SEC Filings

DateFilerForm TypeView
05/24/2024
9:13 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
1:19 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
05/23/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
8:04 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/17/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
3:43 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
05/16/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/16/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
9:27 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2024
9:31 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
3:45 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/07/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/06/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/02/2024
9:43 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
7:57 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
3:15 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/25/2024
9:38 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
10:03 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2024
9:14 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
9:32 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/18/2024
1:33 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D
04/18/2024
9:13 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2024
3:49 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
04/17/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
4:07 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
9:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
2:44 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/12/2024
9:54 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Digitizing the $11T commodities sector with one tiny stock (Ad)

One tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector.

It’s an opportunity that likely won’t stay at these levels for long
04/11/2024
10:57 AM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9
04/11/2024
5:01 AM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T
04/09/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
12:16 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2024
10:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2024
10:37 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
10:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
5:47 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2024
10:27 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
3:12 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
10:13 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2024
10:10 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2024
10:23 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/15/2024
3:46 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
03/15/2024
10:18 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
3:52 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
03/14/2024
10:10 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
7:27 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2024
4:22 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
03/13/2024
3:07 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/13/2024
3:08 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2024
3:12 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2024
10:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
3:36 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G
03/11/2024
10:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
6:05 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/08/2024
2:58 PM
Kynam Capital Management, LP (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G/A
03/08/2024
9:06 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
11:33 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/29/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
9:37 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2024
10:31 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2024
9:31 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
11:47 AM
Kynam Capital Management, LP (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G
02/14/2024
9:42 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)

Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls.

Claim your free seat by clicking here now.
02/09/2024
9:21 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/08/2024
9:18 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2024
4:19 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
02/07/2024
9:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2024
5:57 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2024
3:58 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
02/06/2024
3:52 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-C
02/06/2024
9:45 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2024
4:06 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-C
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MOR) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners